Greg Gianforte bought Mednax Inc (NYSE: MD)
Greg Gianforte (R-MT), a U.S. Representative, has disclosed 1 trade in Mednax Inc (MD) since 2018, a single purchase, worth an estimated $175K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Greg Gianforte bought $100,001 - $250,000 of Mednax Inc (NYSE: MD) on January 29, 2018. Since that trade, MD is down -52.03% against the S&P 500 up +196.01%, an outperformance of -248.04%.
Data updated
Greg Gianforte's MD trades vs the price
MD is down -52.03% since Greg Gianforte bought on January 29, 2018, versus +196.01% for the S&P 500.
Performance since this trade
All Greg Gianforte MD trades
Greg Gianforte & MD trading FAQ
Is it legal for Greg Gianforte to trade Mednax Inc (MD) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Mednax Inc (MD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Greg Gianforte buy MD?
Greg Gianforte disclosed a purchase of $100,001 - $250,000 of Mednax Inc (MD) on January 29, 2018, according to public STOCK Act filings.
How has MD performed since Greg Gianforte's trade?
Since Greg Gianforte bought MD on January 29, 2018, the stock is down -52.03%, versus +196.01% for the S&P 500 over the same period, an outperformance of -248.04%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional MD trades?
Quantellect tracks every disclosed congressional trade in Mednax Inc (MD) on the Mednax Inc congressional trading page, which aggregates filings across all members of Congress.
Greg Gianforte's MD tradesAll congressional filings for Mednax IncGreg Gianforte's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.